Li et al. reported that gal-3 was capable of inducing cellular and systemic insulin resistance [19], while Darrow and Shohet found that gal-3 deficiency exacerbated metabolic disorders [31]. This evidence concerns the gene LGALS3 and Other metabolic disease.